Virulence genotypes and drug resistance of Helicobacter pylori from Vladivostok, Russia: Another feature in the Far East

Microbiology and Immunology

Volumn 56, Issue 3, 2012, Pages 198-202

  Reva, Ivan ^a   Takano, Tomomi ^a   Higuchi, Wataru ^a   Iwao, Yasuhisa ^a   Taneike, Ikue ^a   Nakagawa, Saori ^a   Ike, Masami ^a   Pererva, Oleg ^b   Tarankov, Alexey ^b   Agapov, Mikhail ^c   Rizhkov, Evgeniy ^c   Singur, Olga ^d   Reva, Galina ^d   Potapov, Vladimir ^d   Yamamoto, Tatsuo ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b Far Eastern Regional Medical Center Federal Medical Biologic Agency of Russia   (Russian Federation)

^c Far Eastern Railway Clinical Hospital   (Russian Federation)

^d PACIFIC STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Drug resistance; Far Eastern Russia; Helicobacter pylori; Virulence genotype

Indexed keywords

AMOXICILLIN; CIPROFLOXACIN; CLARITHROMYCIN; DOXYCYCLINE; LEVOFLOXACIN; METRONIDAZOLE; MINOCYCLINE; NORFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TETRACYCLINE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CAGA GENE; CHILD; CONTROLLED STUDY; FEMALE; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; NONHUMAN; NOTE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; RUSSIAN FEDERATION; SCHOOL CHILD; VACA GENE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CHILD; DRUG RESISTANCE, BACTERIAL; FAR EAST; FEMALE; GENOTYPE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; RUSSIA; VIRULENCE; VIRULENCE FACTORS; YOUNG ADULT;

HELICOBACTER PYLORI;

EID: 84859354717     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2011.00425.x     Document Type: Note

References (17)

1. Malfertheiner P., Megraud F., O'morain C., Bazzoli F., El-Omar E., Graham D., Hunt R., Rokkas T., Vakil N., Kuipers E.J. The European Helicobacter Study Group (EHSG). (2007) Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 56: 772-81.
2. Asaka M., Kato M., Takahashi S., Fukuda Y., Sugiyama T., Ota H., Uemura N., Murakami K., Satoh K., Sugano K. (2010) Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter 15: 1-20.
3. Atherton J.C., Blaser M.J. (2009) Coadaptation of Helicobacter pylori and humans: ancient history, modern implications. J Clin Invest 119: 2475-87.
4. Backert S., Tegtmeyer N., Selbach M. (2010) The versatility of Helicobacter pylori CagA effector protein functions: The master key hypothesis. Helicobacter 15: 163-76.
5. Hatakeyama M. (2011) Anthropological and clinical implications for the structural diversity of the Helicobacter pylori CagA oncoprotein. Cancer Sci 102: 36-43.
6. Atherton J.C., Cao P., Peek R.M., Jr., Tummuru M.K., Blaser M.J., Cover T.L. (1995) Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 270: 17771-7.
7. Graham D.Y., Fischbach L. (2010) Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut 59: 1143-53.
8. Gerrits M.M., van Vliet A.H., Kuipers E.J., Kusters J.G. (2006) Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications. Lancet Infect Dis 6: 699-709.
9. De Francesco V., Giorgio F., Hassan C., Manes G., Vannella L., Panella C., Ierardi E., Zullo A. (2010) Worldwide H. pylori antibiotic resistance: a systematic review. J Gastrointest Liver Dis 19: 409-14.
10. Pisareva L.F., Boyarkina A.P., Ushakova I.V. (2009) Gastric cancer incidence in Siberia and Russian Far East. Siberian Journal of Oncology 3: 33-43.
11. Yamaoka Y., Kodama T., Kashima K., Graham D.Y., Sepulveda A.R. (1998) Variants of the 3' region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J Clin Microbiol 36: 2258-63.
12. Clinical and Laboratory Standards Institute. (2011) Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Information Supplement M100-S21. Wayne, PA, USA: CLSI.
13. Bruce M.G., Bruden D.L., Mcmahon B.J., Hennessy T.W., Reasonover A., Morris J., Hurlburt D.A., Peters H., Sacco F., Martinez P., Swenson M., Berg D.E., Parks D., Parkinson A.J. (2006) Alaska sentinel surveillance for antimicrobial resistance in Helicobacter pylori isolates from Alaska native persons, 1999-2003. Helicobacter 11: 581-8.
14. Carothers J.J., Bruce M.G., Hennessy T.W., Bensler M., Morris J.M., Reasonover A.L., Hurlburt D.A., Parkinson A.J., Coleman J.M., Mcmahon B.J. (2007) The relationship between previous fluoroquinolone use and levofloxacin resistance in Helicobacter pylori infection. Clin Infect Dis 44: e5-8.
15. Jang S., Jones K.R., Olsen C.H., Joo Y.M., Yoo Y.J., Chung I.S., Cha J.H., Merrell D.S. (2010) Epidemiological link between gastric disease and polymorphisms in VacA and CagA. J Clin Microbiol 48: 559-67.
16. Li J., Ou Z., Wang F., Guo Y., Zhang R., Zhang J., Li P., Xu W., He Y. (2009) Distinctiveness of the cagA genotype in children and adults with peptic symptoms in South China. Helicobacter 14: 248-55.
17. Uchida T., Kanada R., Tsukamoto Y., Hijiya N., Matsuura K., Yano S., Yokoyama S., Kishida T., Kodama M., Murakami K., Fujioka T., Moriyama M. (2007) Immunohistochemical diagnosis of the cagA-gene genotype of Helicobacter pylori with anti-East Asian CagA-specific antibody. Cancer Sci 98: 521-8.